These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10715531)

  • 1. The immunogenicity of single and combination DNA vaccines against tuberculosis.
    Morris S; Kelley C; Howard A; Li Z; Collins F
    Vaccine; 2000 Apr; 18(20):2155-63. PubMed ID: 10715531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences.
    Li Z; Howard A; Kelley C; Delogu G; Collins F; Morris S
    Infect Immun; 1999 Sep; 67(9):4780-6. PubMed ID: 10456931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with the T cell antigen Mtb 8.4 protects against challenge with Mycobacterium tuberculosis.
    Coler RN; Campos-Neto A; Ovendale P; Day FH; Fling SP; Zhu L; Serbina N; Flynn JL; Reed SG; Alderson MR
    J Immunol; 2001 May; 166(10):6227-35. PubMed ID: 11342645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis.
    Skinner MA; Ramsay AJ; Buchan GS; Keen DL; Ranasinghe C; Slobbe L; Collins DM; de Lisle GW; Buddle BM
    Immunology; 2003 Apr; 108(4):548-55. PubMed ID: 12667217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis.
    Kamath AT; Feng CG; Macdonald M; Briscoe H; Britton WJ
    Infect Immun; 1999 Apr; 67(4):1702-7. PubMed ID: 10085007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.
    Tanghe A; Denis O; Lambrecht B; Motte V; van den Berg T; Huygen K
    Infect Immun; 2000 Jul; 68(7):3854-60. PubMed ID: 10858194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
    Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K
    Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
    Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
    Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation.
    Tollefsen S; Tjelle T; Schneider J; Harboe M; Wiker H; Hewinson G; Huygen K; Mathiesen I
    Vaccine; 2002 Sep; 20(27-28):3370-8. PubMed ID: 12213407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
    Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
    Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved tuberculosis DNA vaccines by formulation in cationic lipids.
    D'Souza S; Rosseels V; Denis O; Tanghe A; De Smet N; Jurion F; Palfliet K; Castiglioni N; Vanonckelen A; Wheeler C; Huygen K
    Infect Immun; 2002 Jul; 70(7):3681-8. PubMed ID: 12065510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.
    Huygen K; Content J; Denis O; Montgomery DL; Yawman AM; Deck RR; DeWitt CM; Orme IM; Baldwin S; D'Souza C; Drowart A; Lozes E; Vandenbussche P; Van Vooren JP; Liu MA; Ulmer JB
    Nat Med; 1996 Aug; 2(8):893-8. PubMed ID: 8705859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses.
    Goter-Robinson C; Derrick SC; Yang AL; Jeon BY; Morris SL
    Vaccine; 2006 Apr; 24(17):3522-9. PubMed ID: 16519971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis.
    Chang-hong S; Xiao-wu W; Hai Z; Ting-fen Z; Li-Mei W; Zhi-kai X
    DNA Cell Biol; 2008 Apr; 27(4):199-207. PubMed ID: 18163878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
    Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
    Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against Mycobacterium tuberculosis.
    Kamath AT; Hanke T; Briscoe H; Britton WJ
    Immunology; 1999 Apr; 96(4):511-6. PubMed ID: 10233735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.
    Lozes E; Huygen K; Content J; Denis O; Montgomery DL; Yawman AM; Vandenbussche P; Van Vooren JP; Drowart A; Ulmer JB; Liu MA
    Vaccine; 1997 Jun; 15(8):830-3. PubMed ID: 9234526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.